- Home
- JVA vs RDHL Comparison
JVA vs RDHL Comparison
Compare JVA & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- RDHL
- Stock Information
- Founded
- JVA 1971
- RDHL 2009
- Country
- JVA United States
- RDHL Israel
- Employees
- JVA N/A
- RDHL N/A
- Industry
- JVA Packaged Foods
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- JVA Consumer Staples
- RDHL Health Care
- Exchange
- JVA Nasdaq
- RDHL Nasdaq
- Market Cap
- JVA 24.7M
- RDHL 4.3M
- IPO Year
- JVA 2005
- RDHL N/A
- Fundamental
- Price
- JVA $4.50
- RDHL $2.18
- Analyst Decision
- JVA
- RDHL
- Analyst Count
- JVA 0
- RDHL 0
- Target Price
- JVA N/A
- RDHL N/A
- AVG Volume (30 Days)
- JVA 223.1K
- RDHL 17.8K
- Earning Date
- JVA 06-13-2025
- RDHL 08-28-2025
- Dividend Yield
- JVA N/A
- RDHL N/A
- EPS Growth
- JVA 856.08
- RDHL N/A
- EPS
- JVA 0.65
- RDHL N/A
- Revenue
- JVA $84,651,329.00
- RDHL $8,042,999.00
- Revenue This Year
- JVA N/A
- RDHL $381.91
- Revenue Next Year
- JVA N/A
- RDHL N/A
- P/E Ratio
- JVA $6.91
- RDHL N/A
- Revenue Growth
- JVA 15.86
- RDHL 23.17
- 52 Week Low
- JVA $1.50
- RDHL $1.71
- 52 Week High
- JVA $9.93
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- JVA 57.20
- RDHL 65.22
- Support Level
- JVA $4.15
- RDHL $2.00
- Resistance Level
- JVA $4.75
- RDHL $2.08
- Average True Range (ATR)
- JVA 0.27
- RDHL 0.09
- MACD
- JVA -0.01
- RDHL 0.03
- Stochastic Oscillator
- JVA 57.35
- RDHL 97.73
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.